Published in Cancer Res on July 15, 1990
Role of formulation vehicles in taxane pharmacology. Invest New Drugs (2001) 1.58
Nanomedicine in the diagnosis and therapy of neurodegenerative disorders. Prog Polym Sci (2007) 1.41
Cytotoxic studies of paclitaxel (Taxol) in human tumour cell lines. Br J Cancer (1993) 1.30
Co-administration of GF120918 significantly increases the systemic exposure to oral paclitaxel in cancer patients. Br J Cancer (2001) 0.99
Exploiting nanotechnology to overcome tumor drug resistance: Challenges and opportunities. Adv Drug Deliv Rev (2013) 0.92
Oral contraception does not alter single dose saquinavir pharmacokinetics in women. Br J Clin Pharmacol (2004) 0.92
GM-144, a novel lipophilic vaginal contraceptive gel-microemulsion. AAPS PharmSciTech (2001) 0.91
Reversal of multidrug resistance by surfactants. Br J Cancer (1992) 0.91
Paclitaxel in a novel formulation containing less Cremophor EL as first-line therapy for advanced breast cancer: a phase II trial. Invest New Drugs (2005) 0.90
Effects of Cremophor EL on distribution of Taxol to serum lipoproteins. Br J Cancer (1994) 0.89
Levels of expression of the mdr1 gene and glutathione S-transferase genes 2 and 3 and response to chemotherapy in multiple myeloma. Br J Cancer (1992) 0.88
Dose-dependent increase of saquinavir bioavailability by the pharmaceutic aid cremophor EL. Br J Clin Pharmacol (2002) 0.88
(18)F-FDG Is a Surrogate Marker of Therapy Response and Tumor Recovery after Drug Withdrawal during Treatment with a Dual PI3K/mTOR Inhibitor in a Preclinical Model of Cisplatin-Resistant Ovarian Cancer. Transl Oncol (2013) 0.85
Effect of the paclitaxel vehicle, Cremophor EL, on the pharmacokinetics of doxorubicin and doxorubicinol in mice. Br J Cancer (1996) 0.84
Enhanced brain delivery of lamotrigine with Pluronic(®) P123-based nanocarrier. Int J Nanomedicine (2014) 0.77
Drug interactions of paclitaxel and docetaxel and their relevance for the design of combination therapy. Invest New Drugs (2001) 0.77
Polymers influencing transportability profile of drug. Saudi Pharm J (2013) 0.76
Comparative study on solid self-nanoemulsifying drug delivery and solid dispersion system for enhanced solubility and bioavailability of ezetimibe. Int J Nanomedicine (2015) 0.76
Safety and efficacy of pralatrexate in the management of relapsed or refractory peripheral T-cell lymphoma. Clin Med Insights Oncol (2012) 0.75
A synergistic effect of Cremophor and beta glucosylceramide to exert liver and sugar protection. J Food Sci Technol (2017) 0.75
British Hypertension Society guidelines for hypertension management 1999: summary. BMJ (1999) 8.80
Quantitative evaluation of Escherichia coli host strains for tolerance to cytosine methylation in plasmid and phage recombinants. Nucleic Acids Res (1989) 7.78
The Regenstrief Medical Record System: a quarter century experience. Int J Med Inform (1999) 7.68
Guidelines for management of hypertension: report of the third working party of the British Hypertension Society. J Hum Hypertens (1999) 6.74
Evaluation of nurse triage in a British accident and emergency department. BMJ (1992) 6.71
Targeted disruption of the three Rb-related genes leads to loss of G(1) control and immortalization. Genes Dev (2000) 5.80
Treatment of rheumatoid arthritis with recombinant human interleukin-1 receptor antagonist. Arthritis Rheum (1998) 4.37
MAOA, maltreatment, and gene-environment interaction predicting children's mental health: new evidence and a meta-analysis. Mol Psychiatry (2006) 4.16
Estimates of general practitioner workload: a review. J R Coll Gen Pract (1989) 4.04
HIV infection among youth in a South African mining town is associated with herpes simplex virus-2 seropositivity and sexual behaviour. AIDS (2001) 3.92
Quantitative competitive polymerase chain reaction for accurate quantitation of HIV DNA and RNA species. Biotechniques (1993) 3.36
Conflicts regarding decisions to limit treatment: a differential diagnosis. JAMA (2000) 3.27
The majority of methylated deoxycytidines in human DNA are not in the CpG dinucleotide. Biochem Biophys Res Commun (1987) 3.08
Quiescence, cycling, and turnover in the primitive hematopoietic stem cell compartment. Exp Hematol (1997) 2.92
Funding of long term care for older people needs to be publicly debated. BMJ (2000) 2.90
Assessment of hepatitis C viremia using molecular amplification technologies: correlations and clinical implications. Ann Intern Med (1995) 2.83
Potential utility of empirical tuberculosis treatment for HIV-infected patients with advanced immunodeficiency in high TB-HIV burden settings. Int J Tuberc Lung Dis (2011) 2.77
Therapeutic benefit of blocking interleukin-6 activity with an anti-interleukin-6 receptor monoclonal antibody in rheumatoid arthritis: a randomized, double-blind, placebo-controlled, dose-escalation trial. Arthritis Rheum (2002) 2.75
JNK2 and IKKbeta are required for activating the innate response to viral infection. Immunity (1999) 2.74
Tissue hyperplasia and enhanced T-cell signalling via ZAP-70 in c-Cbl-deficient mice. Mol Cell Biol (1998) 2.69
A null mutation in the gene encoding a type I interferon receptor component eliminates antiproliferative and antiviral responses to interferons alpha and beta and alters macrophage responses. Proc Natl Acad Sci U S A (1995) 2.57
The reproducibility of central aortic blood pressure measurements in healthy subjects using applanation tonometry and sphygmocardiography. J Hum Hypertens (1999) 2.48
Interferon-gamma release assays do not identify more children with active tuberculosis than the tuberculin skin test. Eur Respir J (2009) 2.44
Risk factors for HIV infection among women in Carletonville, South Africa: migration, demography and sexually transmitted diseases. Int J STD AIDS (2003) 2.40
Exposure to violence during childhood is associated with telomere erosion from 5 to 10 years of age: a longitudinal study. Mol Psychiatry (2012) 2.37
Angiotensin II antagonists for hypertension: are there differences in efficacy? Am J Hypertens (2000) 2.35
Cooperative interactions between the central spindle and the contractile ring during Drosophila cytokinesis. Genes Dev (1998) 2.32
The initial effects on workload and outcome of a public education campaign on early diagnosis and treatment of malignant melanoma in Leicestershire. Br J Dermatol (1990) 2.22
Better blood pressure control: how to combine drugs. J Hum Hypertens (2003) 2.19
Multiparameter analysis of transplantable hemopoietic stem cells: I. The separation and enrichment of stem cells homing to marrow and spleen on the basis of rhodamine-123 fluorescence. Exp Hematol (1985) 2.13
Pathogenesis of post-traumatic syringomyelia. Br J Neurosurg (1992) 2.12
Variations in the accuracy of obstetric procedures and diagnoses on birth records in Washington State, 1989. Am J Epidemiol (1993) 2.07
Cathepsin K knockout mice develop osteopetrosis due to a deficit in matrix degradation but not demineralization. J Bone Miner Res (1999) 2.02
Identification and cloning of a protein kinase-encoding mouse gene, Plk, related to the polo gene of Drosophila. Proc Natl Acad Sci U S A (1993) 1.96
Is social capital a useful conceptual tool for exploring community level influences on HIV infection? An exploratory case study from South Africa. AIDS Care (2002) 1.93
Practice guidelines for primary care physicians: 2003 ESH/ESC hypertension guidelines. J Hypertens (2003) 1.93
Asymmetric methylation in the hypermethylated CpG promoter region of the human L1 retrotransposon. J Biol Chem (1997) 1.89
Devaluation of stimuli contingent on choice: evidence for conditioned reinforcement. J Exp Anal Behav (1987) 1.80
Is aqueduct stenosis a result of hydrocephalus? Brain (1973) 1.80
Targeted therapies in rheumatoid arthritis: the need for action. Rheumatology (Oxford) (1999) 1.78
Molecular cloning and sequencing of cDNAs encoding the entire rat fatty acid synthase. Proc Natl Acad Sci U S A (1989) 1.77
Assessing compliance to antihypertensive medications using computer-based pharmacy records. Med Care (1997) 1.75
Potential for an intervention based on male circumcision in a South African town with high levels of HIV infection. AIDS Care (2003) 1.74
Integrin-linked kinase (ILK): a regulator of integrin and growth-factor signalling. Trends Cell Biol (1999) 1.72
RglB facilitated cloning of highly methylated eukaryotic DNA: the human L1 transposon, plant DNA, and DNA methylated in vitro with human DNA methyltransferase. Nucleic Acids Res (1988) 1.71
Mines, migrancy and HIV in South Africa--managing the epidemic. S Afr Med J (1996) 1.70
Reduction of enzyme levels by propranolol after acute myocardial infarction. Circulation (1978) 1.68
Influence of hypertension, left ventricular hypertrophy, and left ventricular systolic dysfunction on plasma N terminal proBNP. Heart (2000) 1.67
Telomere length in small-for-gestational-age babies. BJOG (2006) 1.66
Management and outcome of posttraumatic syringomyelia. J Neurosurg (1996) 1.66
Aqueduct stenosis. Case review and discussion. J Neurol Neurosurg Psychiatry (1977) 1.65
On the pathogenesis of syringomyelia: a review. J R Soc Med (1980) 1.64
Convergent translational evidence of a role for anandamide in amygdala-mediated fear extinction, threat processing and stress-reactivity. Mol Psychiatry (2012) 1.63
Tuberculosis prevalence surveys: rationale and cost. Int J Tuberc Lung Dis (2008) 1.63
Delayed hematopoietic development in osteopetrotic (op/op) mice. J Exp Med (1993) 1.62
The distending force in the production of "communicating syringomyelia". Lancet (1969) 1.58
Mapping tsetse habitat suitability in the common fly belt of southern Africa using multivariate analysis of climate and remotely sensed vegetation data. Med Vet Entomol (1997) 1.58
The use and misuse of bed-occupancy and waiting-list figures. Lancet (1968) 1.58
Randomized phase III intergroup trial of isotretinoin to prevent second primary tumors in stage I non-small-cell lung cancer. J Natl Cancer Inst (2001) 1.55
An antineuronal antibody cross-reacting with erythrocytes and lymphocytes in systemic lupus erythematosus. Arthritis Rheum (1979) 1.54
Risk of breast cancer in women with benign breast disease. J Natl Cancer Inst (1980) 1.54
Doxazosin for the management of hypertension: implications of the findings of the ALLHAT trial. Am J Hypertens (2001) 1.54
Gene targeting of Desrt, a novel ARID class DNA-binding protein, causes growth retardation and abnormal development of reproductive organs. Genome Res (2001) 1.53
The impact of smoking status, disease stage, and index tumor site on second primary tumor incidence and tumor recurrence in the head and neck retinoid chemoprevention trial. Cancer Epidemiol Biomarkers Prev (2001) 1.50
Spinal extradural arachnoid pouches. Report of two cases. J Neurosurg (1982) 1.49
Mechanical strain-induced extracellular matrix production by human vascular smooth muscle cells: role of TGF-beta(1). Hypertension (2000) 1.49
The hematopoietic deficiencies in osteopetrotic (op/op) mice are not permanent, but progressively correct with age. Exp Hematol (1993) 1.48
Cerebrospinal fluid pressure changes in response to coughing. Brain (1976) 1.42
Biological embedding of stress through inflammation processes in childhood. Mol Psychiatry (2010) 1.42
PET, PTCA, and economic priorities. Clin Cardiol (1990) 1.40
Placement of an intracoronary stent via translumbar puncture. Catheter Cardiovasc Interv (1999) 1.38
Palmar shelf arthroplasty in the rheumatoid wrist. Results of long-term follow-up. J Bone Joint Surg Am (1989) 1.38
The effects of daily recombinant human granulocyte colony-stimulating factor administration on normal granulocyte donors undergoing leukapheresis. Blood (1993) 1.36
The distending force in the production of communicating syringomyelia. Lancet (1970) 1.36
A critical appraisal of posterior fossa surgery for communicating syringomyelia. Brain (1978) 1.36
Simultaneous cerebral and spinal fluid pressure recordings. 2. Cerebrospinal dissociation with lesions at the foramen magnum. Acta Neurochir (Wien) (1981) 1.36
Mentoring program for minority faculty at the University of Pennsylvania School of Medicine. Acad Med (1999) 1.36
Mitogenic activity of Actinomyces viscosus. I. Effects on murine B and T lymphocytes, and partial characterization. J Immunol (1977) 1.34
Beyond the biomedical and behavioural: towards an integrated approach to HIV prevention in the southern African mining industry. Soc Sci Med (1999) 1.32
Prevalence of mutations in the short stature homeobox containing gene (SHOX) in Madelung deformity of childhood. J Med Genet (2002) 1.32
Protective effect of propranolol in threatened myocardial infarction. Lancet (1978) 1.32
Localization of the sites mediating desensitization of the beta(2)-adrenergic receptor by the GRK pathway. Mol Pharmacol (2000) 1.32
Difficult labour as a cause of communicating syringomyelia. Lancet (1977) 1.31
Local excision of T2 and T3 rectal cancers after downstaging chemoradiation. Ann Surg (2001) 1.31
A critical appraisal of drainage in syringomyelia. J Neurosurg (1995) 1.30
Regulation of microvascular permeability by vascular endothelial growth factors. J Anat (2002) 1.30
Mutation in Sos1 dominantly enhances a weak allele of the EGFR, demonstrating a requirement for Sos1 in EGFR signaling and development. Genes Dev (1997) 1.30
A new human breast carcinoma cell line (PMC42) with stem cell characteristics. I. Morphologic characterization. J Natl Cancer Inst (1983) 1.29
Treatment of subdural empyema. J Neurosurg (1981) 1.29
The effect of E. coli host strain on the consensus sequence of regions of the human L1 transposon. Nucleic Acids Res (1989) 1.28
Basal cell adhesion molecule/lutheran protein. The receptor critical for sickle cell adhesion to laminin. J Clin Invest (1998) 1.27
Radiographic studies of the ventricles in syringomyelia. Neuroradiology (1980) 1.26
A physical map and candidate genes in the BRCA1 region on chromosome 17q12-21. Nat Genet (1994) 1.25
Colony-forming cells with high proliferative potential (HPP-CFC). Int J Cell Cloning (1990) 1.23
Cost effectiveness of day and inpatient psychiatric treatment: results of a randomised controlled trial. BMJ (1997) 1.22